Immediate Impact
45 standout
Citing Papers
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Trials and Tribulations of MicroRNA Therapeutics
2024 Standout
Works of Hemant Thacker being referenced
Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose Co-Transporter-2 Inhibitor, in Patients with Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Active-Controlled Trial
2020
Oral lixivaptan effectively increases serum sodium concentrations in outpatients with euvolemic hyponatremia
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Hemant Thacker | 82 | 55 | 52 | 28 | 186 | |
| M M Reidenberg | 29 | 29 | 28 | 24 | 274 | |
| Dzul Azri Mohamed Noor | 51 | 69 | 86 | 38 | 266 | |
| Jacek Rysz | 27 | 35 | 73 | 19 | 283 | |
| Uday Jadhav | 64 | 74 | 198 | 32 | 278 | |
| W. März | 38 | 60 | 69 | 18 | 283 | |
| Roderick Walden | 38 | 49 | 100 | 34 | 274 | |
| Camelia Diaconu | 62 | 33 | 39 | 31 | 276 | |
| N M Kaplan | 65 | 31 | 152 | 15 | 264 | |
| Julia Krzemińska | 64 | 39 | 45 | 10 | 218 | |
| Magdalena Wronka | 64 | 39 | 45 | 10 | 218 |
All Works
Login with ORCID to disown or claim papers
Loading papers...